Back to Clinical Trials
N/ARecruiting

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Sponsored by Leigh R. Hochberg, MD, PhD.

About this study

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

The goal of the BrainGate2 research and development project is to identify the core methods and features for a medical device that could allow people with paralysis, including severe speech impairment, to recover a host of abilities that normally rely on the hands or on speech.

Where this study is enrolling (6)

Show all 6 locations
Who can participate

Inclusion criteria

  • ✓Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders
  • ✓Complete or incomplete tetraplegia (quadriplegia)
  • ✓Must live within a three-hour drive of the Study site
  • ✓(There are additional inclusion criteria)

Exclusion criteria

  • ✕Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
  • ✕Chronic oral or intravenous steroids or immunosuppressive therapy
  • ✕Other serious disease or disorder that could seriously affect ability to participate in the study
  • ✕(There are additional exclusion criteria)

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.